Hospital
Calhoun Liberty Hospital Association, INC.
Calhoun Liberty Hospital Association, INC. was paid $3.14M by Medicaid between Jan 2018 and Nov 2024, across 72 billing codes. Its largest line is 99283, emergency room visit (moderate) — 32% of everything it billed.
33Billing provider infoCALHOUN LIBERTY HOSPITAL ASSOCIATION, INC.
BLOUNTSTOWN, FL 32424
BLOUNTSTOWN, FL 32424
33aNPI1437253085assigned 09/12/2006
33bProvider typeCritical Access Hospital
28Total paid$3.14M
24GClaims89,147
24DCodes billed72
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Florida
Rank by total paid#7 of 12
Median peer was paid$3.14M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,756 | $46K | |
| 2019 | 16,158 | $287K | |
| 2020 | 14,570 | $259K | |
| 2021 | 20,572 | $567K | |
| 2022 | 21,300 | $921K | |
| 2023 | 9,714 | $713K | |
| 2024incomplete | 4,077 | $351K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 32% | 8,826 | 8,155 | $1.02M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 7,191 | 6,473 | $951K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.9% | 3,285 | 2,748 | $313K |
| 36415 | Collection of venous blood by venipuncture | 3.2% | 5,441 | 4,217 | $101K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.7% | 3,056 | 2,927 | $84K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.4% | 619 | 587 | $76K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.4% | 528 | 450 | $74K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.0% | 217 | 195 | $63K |
| 80053 | Comprehensive metabolic panel | 1.7% | 7,604 | 6,197 | $52K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.5% | 3,191 | 3,071 | $47K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 1,723 | 1,558 | $34K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 2,680 | 2,493 | $32K |
60 more codes
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 211 | $30K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 415 | $21K |
| 81001 | <1% | 2,798 | $19K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,412 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,433 | $15K |
| 80061 | Lipid panel | <1% | 1,339 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,187 | $13K |
| 81025 | <1% | 986 | $13K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,416 | $12K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 678 | $12K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,642 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,598 | $10K |
| 81003 | <1% | 988 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 450 | $8K |
| 87634 | <1% | 518 | $7K | |
| 83735 | <1% | 1,715 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 902 | $7K |
| 84484 | <1% | 1,466 | $6K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 28 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 392 | $6K |
| 82550 | <1% | 1,220 | $5K | |
| 82553 | <1% | 1,053 | $5K | |
| 83690 | <1% | 1,045 | $5K | |
| 87186 | <1% | 719 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 519 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,963 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 875 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 867 | $3K |
| 83880 | <1% | 509 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 567 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,119 | $3K |
| G0378 | Hospital observation service, per hour | <1% | 29 | $3K |
| 85610 | <1% | 757 | $2K | |
| 85027 | <1% | 598 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 72 | $2K |
| 85007 | <1% | 524 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 12 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 18 | $1K |
| 85730 | <1% | 210 | $906.55 | |
| 80305 | <1% | 444 | $869.25 | |
| 87807 | <1% | 69 | $851.80 | |
| 84439 | <1% | 423 | $672.15 | |
| 83605 | <1% | 32 | $643.15 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 894 | $528.90 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 461 | $499.90 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 195 | $487.03 |
| 82607 | <1% | 317 | $415.83 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 127 | $326.50 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 165 | $304.99 |
| 82728 | <1% | 34 | $197.72 | |
| 94762 | <1% | 30 | $157.38 | |
| 73030 | <1% | 14 | $127.71 | |
| 80076 | <1% | 18 | $116.21 | |
| 83550 | <1% | 13 | $6.09 | |
| 83540 | <1% | 81 | $4.92 | |
| 82962 | 0% | 80 | $0.00 | |
| 82746 | 0% | 84 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 14 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 12 | $0.00 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROWN, EMILY (CHIEF EXECUITVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Calhoun-Liberty Hospital Association INC | Blountstown, FL | $545K |
| Calhoun-Liberty Hospital Association INC | Blountstown, FL | $179K |
| Joyous OT | Little Rock, AR | $101K |
| Calhoun-Liberty Hospital Association INC | Blountstown, FL | $54K |
| Paramount Medical Solutions LLC | Mishawaka, IN | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.